Decans Medical, a leading domestic orthopedic surgery overall solution provider, closed several hundred million RMB in financing. The funding was led by Fu Zhe Capital and its subsidiary, the National Reform Fund, with participation from Xiuhu Fund, Zhejiang Jiaxin Silk Co., Ltd., Everchanting Fund, Lishui Fuchu Fund, amongst others.

CEC Capital Group acted as the exclusive financial advisor to Decans Medical in this transaction.

This marks the second financing completed within a year since the company's Series B financing earlier this year, with the financing amount exceeding the previous round. This reflects the investors' recognition of the company's performance despite implementation of spine centralized procurement and their confidence in the company's research and development strength and commercialization capability.

After this financing, Decans Medical will expand the construction of production and research bases, develop the nationwide supply chain and marketing, and strengthen product technology and academic advantages.